The Minneapolis/St. Paul Business Journal (Free subscription) | 08/20/2008
St. Jude Medical Inc. was granted approval by the U.S. Food and Drug Administration on a new facility that will manufacture pacemakers and cardiac leads in Arecibo, Puerto Rico. (STJ)
The Earth Times Online Newspaper (Free subscription) | 07/16/2008
CHICAGO (Reuters) - St. Jude Medical Inc on Wednesday said quarterly earnings rose as sales of its implantable cardioverter defibrillators, or ICDs, rose 24 percent over a year ago.
Reuters (Free subscription) | 07/16/2008
CHICAGO (Reuters) - St. Jude Medical Inc on Wednesday said quarterly earnings rose as sales of its implantable cardioverter defibrillators, or ICDs, rose 24 percent over a year ago.
Reuters (Free subscription) | 09/03/2008
... derived from cows are perceived by some physicians to last longer than those from pigs.Medtronic Inc and St. Jude Medical Inc compete in the mitral valve market with a mix of mechanical valves and valves made from pig tissue."Edwards has lost market share to St. Jude and this (product launch) could help turn it around, or at least mitigate those losses," said Tim Nelson, an analyst with...
The Minneapolis/St. Paul Business Journal (Free subscription) | 08/13/2008
St. Jude Medical Inc. has received regulatory approval to market a device used to treat chronic pain, the company said Wednesday. (STJ)
CBC.ca (Free subscription) | 08/09/2008
The Quebec Health Insurance Board has been thwarted in its attempt to force a U.S. medical company to turn over its list of cardiac patients from the province.The Quebec Superior Court said in an Aug. 6 ruling that the board is acting prematurely in demanding information about people who were fitted with products made by St. Jude Medical Inc., based in St. Paul, Minn.The company is the...
Seeking Alpha (Free subscription) | 07/24/2008
Zacks.com submits: St. Jude Medical Inc (STJ) has a history of positive earnings surprises, upward estimate revisions and non cyclical-demand. The company's second-quarter net income was up 20.65% from the same quarter last year, and its stock price has responded, recently advancing back to the 52-week high. Company Description Complete Story »
Market Watch (Free subscription) | 07/16/2008
St. Jude Medical Inc.’s net income for the second quarter climbs 49%, helped by strength in its implantable cardioverter defibrillators.
Market Watch (Free subscription) | 07/16/2008
NEW YORK (MarketWatch) St. Jude Medical Inc. said Wednesday that second-quarter earnings were $201.1 million, or 58 cents a share, compared to $134.8 million in the same period a year ago. Sales were $1.14 billion, versus $947.3 million a year ago. Favorable foreign currency translation comparisons increased second-quarter sales by approximately $64 million. Reported net earnings for...
